Literature DB >> 21427352

Imaging features of lymphangioleiomyomatosis: diagnostic pitfalls.

Nilo A Avila1, Andrew J Dwyer, Joel Moss.   

Abstract

OBJECTIVE: The objective of this article is to illustrate CT findings that may be misinterpreted and lead to unnecessary biopsy or surgical procedures in patients with lymphangioleiomyomatosis.
CONCLUSION: Sequelae of pleurodesis, acutely hemorrhagic renal angiomyolipomas, and lymphatic involvement with lymphangioleiomyomatosis including enlarged lymph nodes and lymphangioleiomyomas are common benign conditions seen in patients with lymphangioleiomyomatosis that may be misdiagnosed on CT for malignancy and may prompt unnecessary biopsy and surgery. Ruptured abdominal pelvic lymphangioleiomyomas may be mistaken for appendicitis and other acute abdominal pelvic events.

Entities:  

Mesh:

Year:  2011        PMID: 21427352      PMCID: PMC3176725          DOI: 10.2214/AJR.10.4185

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  16 in total

1.  Diagnosis of lymphangioleiomyomatosis by CT-guided retroperitoneal biopsy.

Authors:  P J Pickhardt; E A Kazerooni; A Flint
Journal:  Clin Radiol       Date:  2000-06       Impact factor: 2.350

Review 2.  Pleurodesis: everything flows.

Authors:  D Bouros; M Froudarakis; N M Siafakas
Journal:  Chest       Date:  2000-09       Impact factor: 9.410

Review 3.  Lymphangioleiomyomatosis: pulmonary and abdominal findings with pathologic correlation.

Authors:  Esther Pallisa; Pilar Sanz; Antonio Roman; Joaquim Majó; Jordi Andreu; José Cáceres
Journal:  Radiographics       Date:  2002-10       Impact factor: 5.333

4.  Atypical presentation of lymphangioleiomyomatosis as acute abdomen: CT diagnosis.

Authors:  Yuen-Yee Wong; Tai-Kong Yeung; Winnie Chiu-Wing Chu
Journal:  AJR Am J Roentgenol       Date:  2003-07       Impact factor: 3.959

5.  Lymphangioleiomyomatosis. Clinical course in 32 patients.

Authors:  J R Taylor; J Ryu; T V Colby; T A Raffin
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

6.  European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis.

Authors:  S R Johnson; J F Cordier; R Lazor; V Cottin; U Costabel; S Harari; M Reynaud-Gaubert; A Boehler; M Brauner; H Popper; F Bonetti; C Kingswood
Journal:  Eur Respir J       Date:  2010-01       Impact factor: 16.671

Review 7.  The management of renal angiomyolipoma.

Authors:  J E Oesterling; E K Fishman; S M Goldman; F F Marshall
Journal:  J Urol       Date:  1986-06       Impact factor: 7.450

8.  Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas.

Authors:  N A Avila; J Bechtle; A J Dwyer; V J Ferrans; J Moss
Journal:  Radiology       Date:  2001-11       Impact factor: 11.105

9.  CT diagnosis of renal angiomyolipoma: the importance of detecting small amounts of fat.

Authors:  M A Bosniak; A J Megibow; D H Hulnick; S Horii; B N Raghavendra
Journal:  AJR Am J Roentgenol       Date:  1988-09       Impact factor: 3.959

10.  Case report: lymphangiomyomatosis with spontaneous peritoneal rupture.

Authors:  W C Peh; S Law; M Fok; H Ngan
Journal:  Br J Radiol       Date:  1994-06       Impact factor: 3.039

View more
  4 in total

1.  Effects of sirolimus in lymphangioleiomyomatosis patients on lung cysts and pulmonary function: long-term follow-up observational study.

Authors:  Cherry Kim; Kyung-Hyun Do; Jaehyung Cha; Jin Woo Song; Sang Min Lee; Ki Yeol Lee
Journal:  Eur Radiol       Date:  2019-08-30       Impact factor: 5.315

2.  EPIDEMIOLOGY, PATHOGENESIS and DIAGNOSIS of LYMPHANGIOLEIOMYOMATOSIS.

Authors:  Angelo M Taveira-DaSilva; Joel Moss
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-07       Impact factor: 0.694

Review 3.  Management of lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Joel Moss
Journal:  F1000Prime Rep       Date:  2014-12-01

Review 4.  Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis.

Authors:  Angelo M Taveira-DaSilva; Joel Moss
Journal:  Clin Epidemiol       Date:  2015-04-07       Impact factor: 4.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.